Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 299, doi. 10.1002/pros.20187
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2004 AND VI 61 AND IP 4
Results: 10
1
2
Author response: The Quebec screening study shows a 62% decrease in prostate cancer death.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 373, doi. 10.1002/pros.20185
- By:
- Publication type:
- Article
3
Erratum: Monika Schmelz, Anne E. Cress, Jean Barrera, Kathy M. McDaniel, Tracy L. Davis, Laura Fuchs, Bruce L. Dalkin, Raymond B. Nagle. PEAZ-1: A new human prostate neoplastic epithelial cell line. Prostate 2001;48:7992.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 375, doi. 10.1002/pros.20175
- Publication type:
- Article
4
Labrie et al.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 371, doi. 10.1002/pros.20165
- By:
- Publication type:
- Article
5
A misleading paper on prostate cancer screening.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 372, doi. 10.1002/pros.20160
- By:
- Publication type:
- Article
6
Androgen deprivation therapy for prostate cancer: Current status and future prospects.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 332, doi. 10.1002/pros.20115
- By:
- Publication type:
- Article
7
Co-operative functions between nuclear factors NF?B and CCAT/enhancer-binding protein- (C/EBP-) regulate the IL-6 promoter in autocrine human prostate cancer cellsThe content of this article does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 354, doi. 10.1002/pros.20113
- By:
- Publication type:
- Article
8
The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinomaWork was accomplished at Department of Pathology, Ljudevit Jurak University, Sestre Milosrdnice University Hospital, Vinogradska 29, 10000 Zagreb, Croatia.The study was presented in part at the XIX ESP Congress, Ljubljana, Slovenia, September 510th, 2003.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 324, doi. 10.1002/pros.20109
- By:
- Publication type:
- Article
9
Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferationShinji Sakamoto and Masahiro Yokoyama contributed equally to this study.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 305, doi. 10.1002/pros.20098
- By:
- Publication type:
- Article
10
Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
- Published in:
- Prostate, 2004, v. 61, n. 4, p. 318, doi. 10.1002/pros.20087
- By:
- Publication type:
- Article